Aspen Aerogels (NYSE: ASPN) reported Q4 EPS of ($0.50), $0.21 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $31.5 million versus the consensus estimate of $34.46 million.

GUIDANCE:

Aspen Aerogels sees FY2022 EPS of ($1.95)-($2.07), versus the consensus of ($0.98). Aspen Aerogels sees FY2022 revenue of $145-155 million, versus the consensus of $151 million.

For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.